8-K
Current Report
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-005470
Results of operations · Executive or director change
- Item 2.02 Results of operations and financial condition
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading fdmt-20251231.htm…